Syin Dora, Woreta Tinsay, Chang David C, Cameron John L, Pronovost Peter J, Makary Martin A
Center for Outcomes Research, Department of Surgery, John Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
J Surg Res. 2007 Nov;143(1):88-93. doi: 10.1016/j.jss.2007.03.035.
Patients consenting for pancreas surgery are often quoted an operative risk of 1% to 3% based on the literature. However, these results are often from centers of excellence, and as a result the literature mortality rates may not be representative or generalizable.
A MEDLINE search was performed to identify the major studies of pancreaticoduodenectomy (PD) and total pancreatectomy (TP) over a 6-y period (January 1998-December 2003). To obtain a literature-based mortality rate, we performed a meta-analysis of these published series and compared them with actual in-hospital mortality rates based on a representative 20% sample of hospital data in 37 states (the Nationwide Inpatient Sample). The sample included approximately 8 million patient records per year. Literature versus actual mortality rates were compared for the same 6-y period and stratified by academic versus nonacademic medical centers.
We identified 16 major studies on PD and TP totaling 3641 patients with an overall mortality rate of 3.2% (range 0%-9.3%). The actual mortality rate based on the Nationwide Inpatient Sample (n = 7604) was 2.4-fold higher than the literature rate (adjusted rate of 7.6% versus 3.2%, P < 0.0001). All literature-based series were published from academic medical centers. By contrast, in the national database, 26.3% of PDs (2003/7604) were performed at nonacademic medical centers with a mortality rate of 11.4% (229/2003). The actual mortality rate at academic medical centers was lower than nonacademic medical centers (6.4% (360/5601), P < 0.0001), but still higher than the literature-based rate of 3.2% (P < 0.0001).
Mortality rates for pancreatic resections in actual practice are 2.4-fold higher than those reported in the literature. Proper informed consent for surgical procedures should include an accurate description of the risks, using actual local and national mortality rates.
根据文献,同意接受胰腺手术的患者通常被告知手术风险为1%至3%。然而,这些结果往往来自卓越中心,因此文献中的死亡率可能不具有代表性或不可推广。
进行MEDLINE检索,以确定6年期间(1998年1月至2003年12月)胰十二指肠切除术(PD)和全胰切除术(TP)的主要研究。为了获得基于文献的死亡率,我们对这些已发表的系列进行了荟萃分析,并将其与基于37个州(全国住院患者样本)20%代表性医院数据的实际住院死亡率进行比较。该样本每年包括约800万份患者记录。比较了同一6年期间文献死亡率与实际死亡率,并按学术医疗中心与非学术医疗中心进行分层。
我们确定了16项关于PD和TP的主要研究,共3641例患者,总死亡率为3.2%(范围0%-9.3%)。基于全国住院患者样本(n = 7604)的实际死亡率比文献报道的死亡率高2.4倍(调整率分别为7.6%和3.2%,P < 0.0001)。所有基于文献的系列均发表于学术医疗中心。相比之下,在国家数据库中,26.3%的PD(2003/7604)在非学术医疗中心进行,死亡率为11.4%(229/2003)。学术医疗中心的实际死亡率低于非学术医疗中心(6.4%(360/5601),P < 0.0001),但仍高于基于文献的3.2%的死亡率(P < 0.0001)。
实际临床实践中胰腺切除术的死亡率比文献报道的高2.4倍。手术程序的适当知情同意应包括使用实际的当地和全国死亡率准确描述风险。